发明名称 |
Triterpene saponins, methods of synthesis, and uses thereof |
摘要 |
<p>The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and clinical evaluation.</p> |
申请公布号 |
AU2009233757(B2) |
申请公布日期 |
2015.05.07 |
申请号 |
AU20090233757 |
申请日期 |
2009.04.08 |
申请人 |
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH |
发明人 |
PERL, NICHOLAS;LIVINGSTON, PHILIP;RAGUPATHI, GOVIND;GIN, DAVID;DENG, KAI;WON, ANNIE;ADAMS, MICHELLE |
分类号 |
C07H15/24;A61K31/704;A61P37/04 |
主分类号 |
C07H15/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|